Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$128M Buy
10,932,468
+3,795,799
+53% +$52.2M 4.06% 9
2026
Q2
$123M Buy
7,136,669
+358,280
+5% +$6.67M 4.04% 9
2026
Q1
$132M Buy
6,778,389
+309,535
+5% +$7.08M 4.81% 5
2025
Q4
$125M Sell
6,468,854
-68,173
-1% -$1.31M 4.82% 5
2025
Q3
$125M Sell
6,537,027
-5,175
-0.1% -$107K 4.99% 4
2025
Q2
$141M Sell
6,542,202
-742,625
-10% -$12.2M 6.36% 1
2025
Q1
$98.6M Sell
7,284,827
-448,203
-6% -$6.1M 5.07% 3
2024
Q4
$123M Sell
7,733,030
-8,817
-0.1% -$139K 5.67% 2
2024
Q3
$122M Buy
+7,741,847
New +$226M 5.99% 1

Other funds holding QXO

Samantha McLemore's QXO Position: Q3 2026 in Review

Samantha McLemore increased its QXO (QXO) stake by 53% in Q3 2026, buying an estimated $52.2M and bringing the position to 10,932,468 shares worth $128M. The position accounts for 4.06% of the portfolio, ranked #9.

Samantha McLemore first reported a position in QXO in Q3 2024 and has held it in 9 quarters since. The position peaked at $141M in Q2 2025. 761 funds tracked by Wall St. Rank hold QXO as of Q3 2026.

  • Samantha McLemore held 10,932,468 shares of QXO worth $128M as of Q3 2026.
  • Samantha McLemore bought 3,795,799 QXO shares in Q3 2026, an estimated $52.2M.
  • QXO made up 4.06% of Samantha McLemore's portfolio in Q3 2026, its #9 holding.
  • Samantha McLemore first reported a position in QXO in Q3 2024 and has held it in 9 quarters since.
  • Samantha McLemore's QXO position peaked at $141M in Q2 2025.
  • 761 funds tracked by Wall St. Rank held QXO as of Q3 2026.

Based on Patient Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.